Premium Quality Anti-Tumor API Docetaxel CAS 114977-28-5

Bayanan Samfura

Suna:Docetaxel

Lambar CAS:114977-28-5

Tsarin sinadarai:Saukewa: C45H57NO14

Ƙayyadaddun bayanai:99%

Launi:farin foda

Source:Semi-hada tare da 10-DAB

Nau'in:APIs

Aiki

Domin maganin ciwon daji na nono da ya ci gaba, ciwon huhu wanda ba ƙananan cell ba, ana kuma amfani da shi don magance ciwace-ciwacen daji kamar kansa da wuyansa, ciwon daji na huhu, ciwon daji na ciki, da ciwon daji na ovarian.

Kamar paclitaxel, yana da tasiri mai kyau akan ciwon daji na huhu mara ƙananan cell da kuma ciwon nono, kuma ana iya amfani dashi don ciwon kai da wuyansa da ciwon daji na ovarian.

Tarihin Hande GMP

1.In 1996, da ingancin tsarin da aka kafa da kuma samu DMF.

2.In 2004, FDA on-site dubawa samu CGMP takardar shaidar.

3.A cikin 2009, an sami Semi-synthetic paclitaxel DMF da na halitta paclitaxel CEP.

4.A cikin 2011, an sami Semi-synthetic paclitaxel CEP.

5.In 2012, wuce TGA on-site dubawa, samu GMP takardar shaida, da kuma wuce da FDA on-site dubawa.

6.A cikin 2013, ya wuce shafin CGMP.

7.In 2015, India aka rajista da Japan rajista.

Hande samar iya aiki

Zagayen samarwa:Kwanaki 7.

Ƙarfin samarwa na Hande:akwai kaya, akwai tsari, kuma yawan samarwa yana yiwuwa.

Ayyukanmu

1.Kayayyaki:Samar da high quality-high-tsarki shuka ruwan 'ya'ya, Pharmaceutical albarkatun kasa, da Pharmaceutical matsakaici.

2.Ayyukan fasaha:Abubuwan da aka keɓance tare da ƙayyadaddun bayanai na musamman bisa ga buƙatun abokin ciniki.

Yunnan hande Biotechnology Co., Ltd., wanda aka kafa a watan Agustan 1993, babban kamfani ne mai fasaha wanda ya kware kan bincike da bunkasa fasahar kere-kere.Bayan shekaru na ci gaba, hande ya kafa ingantaccen tsarin inganci, yana sarrafa ingancin samfuran bisa ga ma'auni masu girma, kuma ya haɓaka ƙimar fitarwa na ƙarfin samarwa.Kayayyakin sa sun wuce takaddun shaida na dokoki da ƙa'idodi na ƙasashen duniya, kuma sun zama masana'antar albarkatun ƙasa wanda ke sa kowa ya sami nutsuwa.